MIM
SION

MetLife Investment Management’s Sionna Therapeutics SION Stock Holding History

MetLife Investment Management’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$343K Hold
8,565
– – ﹤0.01% 1940
2025
Q4 		$352K Buy
8,565
+532
+7% +$20.2K ﹤0.01% 1961
2025
Q3 		$236K Hold
8,033
– – ﹤0.01% 2224
2025
Q2 		$139K Buy
+8,033
New +$105K ﹤0.01% 2376

Other funds holding SION

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MetLife Investment Management's SION Position: Q1 2026 in Review

MetLife Investment Management held its Sionna Therapeutics (SION) position steady in Q1 2026 at 8,565 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #1940.

MetLife Investment Management first reported a position in SION in Q2 2025 and has held it in 4 quarters since. The position peaked at $352K in Q4 2025. 122 funds tracked by Wall St. Rank hold SION as of Q1 2026.

  • MetLife Investment Management held 8,565 shares of Sionna Therapeutics worth $343K as of Q1 2026.
  • MetLife Investment Management left its Sionna Therapeutics share count unchanged in Q1 2026.
  • Sionna Therapeutics made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1940 holding.
  • MetLife Investment Management first reported a position in Sionna Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • MetLife Investment Management's Sionna Therapeutics position peaked at $352K in Q4 2025.
  • 122 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.